Looking Ahead to 2026: Setting New Standards in Pharmacy Benefits Management
- Ken Kemker
- Jan 4
- 2 min read
In 2026, pharmacy benefits will require greater accountability from PBM partners. Plan sponsors are increasingly seeking complete visibility into their pharmacy spend and requesting partners who serve their interests first.
At DisclosedRx, we're proud to lead this transformation as The Fiduciary and Fully Disclosed PBM®, setting the standard for what plan sponsors should expect from their pharmacy benefits management relationship.
The Growing Demand for Full Disclosure
The traditional PBM model, often clouded by complex pricing structures and obscured revenue streams, is rapidly becoming obsolete. Forward-thinking organizations are recognizing that Full Disclosure isn't just a phrase; it's a fundamental requirement for effective cost management and optimal member care.
As The Fiduciary and Fully Disclosed PBM®, we're seeing more plan sponsors embrace our model, which includes:
100% pass-through of all drug pricing
100% pass-through of all rebates
A single, clearly defined administrative fee
Complete visibility into every aspect of drug spend
Why 2026 Will Be Different
The coming year represents a pivotal moment in pharmacy benefits management. Our Enhanced Specialty Cost Control programs demonstrate how Full Disclosure drives real results, delivering as much as 75% savings per fill while reducing member copays, often to zero. This approach proves that plan sponsors can provide exceptional benefits while maintaining cost control through genuine partnership with their PBM.
The Path Forward
Ask your current or prospective PBM these essential questions:
Do they act as a fiduciary, contractually bound to act in your best interests?
Do they contractually guarantee 100% pass-through of all drug pricing?
Are 100% of rebates passed through to your plan?
Can they clearly explain all revenue sources?
Conclusion
As we move into 2026, the choice is clear: continue with traditional PBM practices or embrace fiduciary partnership and Full Disclosure. At DisclosedRx, we're proud to lead this transformation, proving that when you combine fiduciary commitment and Full Disclosure with innovation and exceptional service, you create a model that truly serves the best interests of plans and their members.
Comments